Marked Chart Marked Chart Closed

The Marked Chart Wire · Business

Pharma Deals

AbbVie signs deal for DISCO Pharma bispecific cancer drug

AbbVie has agreed to a deal worth up to $2.54 billion for a bispecific cancer drug from DISCO Pharma.

ABBV-0.9%

Illustration for the Business desk

The stocks in this story

  1. ABBV-0.9%AbbVie$283.54

Prices from Based on Thu, Nov 19 close · Opens Fri 9:30 AM ET. Each tile opens the stock's chart and news.

New to this? Read: Reading a stock chart

More Business news

Fast headlines, summarized. Not verified and not advice. Check the full story before you act.